Physician

Mathew Alan Davey, M.D.

According to 2025 Medicare claims, Mathew Davey, M.D. (NPI: 1851568703) practices dermatology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is ADVANCED DERMATOLOGY OF THE MIDLANDS PC (NPI: 1497182273; TIN: 46-3723920) and primary practice location at 51503-5288. Davey is affiliated with the Think ACO, LLC (ACO ID: A2773) and Nebraska Health Network, LLC (ACO ID: A3273), participating under the MSSP model.

Davey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 947 traditional Medicare patients, billed 5,624 HCPCS/CPT codes, and received $328,839 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 927 prescription claims across 392 beneficiaries totaling $542,368 in drug costs, led by Erivedge (Vismodegib). Open Payments data shows 87 records totaling $1,339. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $202,057 to $542,368. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,194	7,116	$316,665
2016	1,326	8,378	$370,102
2017	1,342	7,413	$316,383
2018	1,334	7,462	$335,695
2019	1,273	7,919	$380,450
2020	1,173	7,653	$373,000
2021	1,157	8,205	$449,162
2022	1,194	7,018	$380,097
2023	1,116	5,748	$341,700
2024	947	5,624	$328,839

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	492	1,238	$202,057
2016	504	1,288	$284,737
2017	490	1,240	$241,343
2018	436	1,028	$397,649
2019	442	1,077	$508,533
2020	409	992	$313,192
2021	455	1,065	$347,336
2022	417	972	$437,590
2023	365	866	$426,872
2024	392	927	$542,368

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	298	363	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	676	968	$55
11102	Biopsy of related skin growth, first growth	270	329	$51
17000	Destruction of precancer skin growth, 1 growth	440	639	$32
17003	Destruction of precancer skin growth, 2-14 growths	324	1,999	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erivedge	Vismodegib	16	470	$222,248
Dupixent Pen	Dupilumab	24	658	$96,733
Fluorouracil	Fluorouracil	76	2,023	$6,523
Clobetasol Propionate	Clobetasol Propionate	55	1,608	$1,793
Metronidazole	Metronidazole	32	763	$1,644

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$1,339	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mathew Alan Davey, M.D.?

Tedicare shows public-source Medicare data for Mathew Alan Davey, M.D. (NPI 1851568703), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mathew Alan Davey, M.D. have ACO affiliation data?

Mathew Alan Davey, M.D. is shown with ACO affiliation data for Think ACO, LLC (MSSP, ACO ID A2773) and Nebraska Health Network, LLC (MSSP, ACO ID A3273).

What billing organization is linked to Mathew Alan Davey, M.D.?

Mathew Alan Davey, M.D. is linked to ADVANCED DERMATOLOGY OF THE MIDLANDS PC (billing NPI 1497182273) in the available physician profile data.

Does Mathew Alan Davey, M.D. have Open Payments data?

Mathew Alan Davey, M.D. has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.